By Justin Petrone

BlueGnome has penned a supply agreement with SciGene that will give the company an entry into the microarray hardware market and enable it to further secure its global footprint.

Under the terms of the deal, SciGene will manufacture BlueGnome's new range of ClearLab hybridization and wash systems.

Previously, Cambridge, UK-based BlueGnome had recommended SciGene's equipment for use with its arrays for constitutional and cancer cytogenetics and pre-implantation genetic screening.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.